List view / Grid view

heart failure

Filter the results



NICE recommends heart failure drug Entresto

27 April 2016 | By Victoria White, Digital Content Producer

The National Institute for Health and Care Excellence (NICE) has recommended Novartis’ Entresto (sacubitril valsartan) for some people with heart failure.


EC grants marketing authorisation to Entresto

25 November 2015 | By Victoria White

The European Commission has granted marketing authorisation to Novartis’ Entresto (sacubitril/valsartan) for the treatment of adult patients with symptomatic chronic heart failure with reduced ejection fraction (HFrEF).